comparemela.com

Latest Breaking News On - Yevgeny brudno - Page 1 : comparemela.com

Takara Bio Launches First Commercial Dissolvable Microfluidic Lentiviral Transduction Enhancer

SAN JOSE, Calif. (BUSINESS WIRE) May 6, 2024

United statesTakara bioLiz quinnCarol louYevgeny brudnoDepartment of biomedical engineeringUniversity of north carolinaTakara bio incSchool of pharmacyAmerican society of geneTakara bio united states incCarolina state universityInternational society for cell gene therapyBio united statesTransduction spongeLentix transduction sponge

Implanted System Rapidly Generates CAR-T Cells to Combat Tumors in Mice

An implantable system can both produce and release CAR-T cells in the body to combat cancer, a mouse study shows.

Yevgeny brudnoJohanna olweusNature technologyReuters healthCarolina state university in raleighDepartment of cancer immunologyUniversity of osloMultifunctional alginate scaffoldsNorth carolina state universityCancer immunologyCancer researchOslo university hospital radiumhospitaletNature biotechnologyBiologic therapyChimeric antigen receptort cell therapyChimeric antigen receptors

Implantable technology could enable in vivo CAR T therapy

Pre-clinical research demonstrates the potential of a new implantable biotechnology called MASTER to produce and release CAR T cells in vivo.

North carolina state universityNorth carolinaUnited statesUniversity of north carolinaYevgeny brudnoPritha agarwallaNational centerUniversity of north carolina at chapel hillCarolina biotechnology centerNational institutes of healthCarolina state universityTranslational sciencesMultifunctional alginate scaffoldsChapel hillNorth carolina biotechnology centerAdvancing translational sciences

N C Researchers Develop Implant That Produces Cancer-fighting CAR-T Cells | North Carolina Biotechnology Center

A team of North Carolina scientists, with early grant support from NCBiotech, has developed an implantable scaffold resembling a “mini marshmallow” that produces and releases CAR-T cells for attacking cancerous tumors.

North carolina state universityNorth carolinaUnited statesUniversity of north carolinaYevgeny brudnoPritha agarwallaFrances liglerNational cancer instituteUniversity of north carolina at chapel hillTexasam universityCarolina biotechnology centerDrug administrationLineberger cancer centerCarolina state universityElla maruChapel hill

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.

United statesYevgeny brudnoPritha agarwallaFrances liglerEmily hendersonDepartment of microbiologyUniversity of north carolina at chapel hillTexasam universityLineberger cancer centerCarolina state universityImmunology programNorth carolina state universityNorth carolinaChapel hillMultifunctional alginate scaffoldsGianpietro dotti

vimarsana © 2020. All Rights Reserved.